2025 annual financial data
Virax Biolabs Group 2025 Operating margin
Virax Biolabs Group 2025 operating margin with verified reported values.
Direct answer
Operating margin was -97,344.76%.
Operating income was -6,162,897 USD and net income was -6,061,247 USD.
Operating cash flow was -4,563,576 USD.
Get free Virax Biolabs Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,331 USD
- Operating income
- -6,162,897 USD
- Net income
- -6,061,247 USD
- Operating cash flow
- -4,563,576 USD